Biocryst Pharma Inc (NQ: BCRX )

8.430 +0.420 (+5.24%)

Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Biocryst Pharma Inc

< Previous 1 2 3 4 5 6 7 Next >

Biotech Bloodbath Continues Despite Gene-Editing Deals For Pfizer, Bayer

January 10, 2022

Pfizer and Bayer inked deals with several companies in gene-editing.

Via Investor's Business Daily

45 Stocks Moving In Monday's Mid-Day Session

January 10, 2022

Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares climbed 71.5% to $5.88. Zynga Inc. (NASDAQ: ZNGA) gained 45.7% to $8.74 after the company announced it will be acquired...

Via Benzinga

3 Stocks Insiders Are Buying

November 26, 2021

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, t...

Via Benzinga

Analyzing BioCryst Pharmaceuticals's Unusual Options Activity

August 11, 2021

BioCryst Pharmaceuticals (NASDAQ:BCRX) shares experienced...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021

December 10, 2021

Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE:

Via Benzinga

BioCryst Shares Gain As Royalty Pharma Buys Additional Interests In BCX9930, Orladeyo

November 22, 2021

Royalty Pharma plc (NASDAQ: RPRX) and OMERS Capital Markets have announced transactions worth $350 million in new funding in BioCryst Pharmaceuticals...

Via Benzinga

7 Top Growth Stocks to Buy as We Step Into November

November 12, 2021

Here are seven top growth stocks investors may want to consider when looking at options in this hyper-growth market right now.

Via InvestorPlace

86 Biggest Movers From Yesterday

November 04, 2021

Gainers FAT Brands Inc. (NASDAQ: FATBB) shares gained 99.2% to settle at $15.44. FAT Brands recently announced plans to acquire Fazoli’s Restaurant Chain for $130 million....

Via Benzinga

BioCryst Pharmaceuticals (BCRX) Q3 2021 Earnings Call Transcript

November 03, 2021

BCRX earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Exposures Financial

Here's Why BioCryst Pharmaceuticals Stock Is Losing Ground Today

November 03, 2021

The biotech's third quarter was a good one, once you look past the top-line numbers.

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's Intraday Session

November 03, 2021

Gainers iRhythm Technologies (NASDAQ:IRTC) stock moved upwards by 52.78% to $117.34 during Wednesday's regular session. iRhythm Technologies's stock is trading at...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

November 03, 2021

Gainers Glaukos (NYSE:GKOS) stock increased by 25.55% to $56.58 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.6 billion...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session

October 20, 2021

Gainers Tenet Healthcare (NYSE:THC) stock r...

Via Benzinga

2 Super-Charged Growth Stocks to Buy Now

October 13, 2021

These two small drugmakers are poised for a long-winded growth spurt.

Via The Motley Fool

NICE Recommends BioCryst's Hereditary Angioedema Med

September 16, 2021

The U.K.'s National Institute for Health and Care Excellence (NICE) has recommended BioCryst Pharmaceuticals Inc's (NASDAQ: BCRX) Orladeyo (berotralstat)...

Via Benzinga

US Government Exercises Option To Buy Additional Doses Of BioCryst's Flu Med

September 01, 2021

The U.S. Department of Health and Human Services (HHS) has exercised its option to purchase an additional 10,000 doses of BioCryst Pharmaceuticals Inc's (...

Via Benzinga

The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO

August 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)...

Via Benzinga

Exposures COVID-19

Analyzing BioCryst Pharmaceuticals's Unusual Options Activity

August 16, 2021

BioCryst Pharmaceuticals (NASDAQ:BCRX) shares experienced unusual options activity on Monday. The stock price moved down to $15.44 following the option alert. Sentiment: BULLISH...

Via Benzinga

BioCryst Stock Jumps After Pulling Out $200M Equity Raise

August 11, 2021

BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) has withdrawn its proposed public offering of $200 million of its stock and pre-funded warrants. The Company says...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

August 11, 2021

Gainers CohBar (NASDAQ:CWBR) stock moved upwards by 68.21% to $2.17 during Wednesday's pre-market session. The company's market cap stands at $134.0 million. The...

Via Benzinga

22 Stocks Moving in Wednesday's Pre-Market Session

August 11, 2021

Gainers CohBar, Inc. (NASDAQ: CWBR) shares rose 78.3% to $2.30 in pre-market trading after the company reported results from the Phase 1a/1b study of CB4211 under development for...

Via Benzinga

The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering

August 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...

Via Benzinga

Exposures Product Safety

85 Biggest Movers From Yesterday

August 11, 2021

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX...

Via Benzinga

54 Stocks Moving In Tuesday's Mid-Day Session

August 10, 2021

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy...

Via Benzinga

28 Stocks Moving in Tuesday's Pre-Market Session

August 10, 2021

Gainers Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares rose 38.6% to $66.88 in pre-market trading after the company reported better-than-expected Q2 earnings and also...

Via Benzinga

The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO

August 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

BioCryst Pharmaceuticals (BCRX) Q2 2021 Earnings Call Transcript

August 06, 2021

BCRX earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Exposures Financial

Why BioCryst Pharmaceuticals Rose 8% on Thursday

August 05, 2021

The company's first commercial drug launch keeps exceeding expectations.

Via The Motley Fool

Topics Earnings

Exposures Financial Product Safety

BioCryst Pharma Stock Heads Higher Thursday: Here's Why

August 05, 2021

BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) shares were trading higher Thursday after the company reported second-quarter financial results. The company reported revenue of...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session

August 05, 2021

Gainers Ensysce Biosciences (NASDAQ:ENSC) shares rose 42.78% to $5.84 during Thursday's pre-market session. The company's market cap stands at $141.7 million....

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.